TLR4 and liver dysplastic nodule: WT1+ podocytes were significantly reduced at week 12 and 24 compared to non-diabetic controls but this reduction was significantly attenuated in TLR4−/− diabetic mice versus WT-DN at week 24 (Figure 4H & I).